ATCC Announces New Award from the National Cancer Institute to Process Biomaterials for Cancer Research

ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cell lines and microorganisms.
Published on : Published by : BioBuzz Media

ATCC, the world’s premier biological materials management and standards organization, today announced that it has been selected as an awardee for the National Cancer Institute’s (NCI) Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services contract. Under this contract, ATCC will compete to provide technical support for studies and other research activities associated with ongoing and new research programs conducted in DCEG Branches and Laboratories within the National Cancer Institute (NCI) and part of the National Institutes of Health (NIH). ATCC will support multidisciplinary domestic and international studies with diverse study designs in epidemiology, exposure assessment, genetics, and clinical research that include retrospective and prospective cohort studies, case-control studies, family studies, cross-sectional molecular epidemiology studies, exposure assessment studies, and randomized clinical trials.

Top Biotech Companies Hiring in Maryland: Summer 2022 Edition

Published on : Published by : Steven Surdez

Here’s our Summer 2022 Roundup of top Maryland life sciences companies with more than 10 active job listings across a wide range of fields and experience levels. 

ATCC Expands Leadership Team to Provide Vision and Growth Strategy

Published on : Published by : BioBuzz Media

ATCC, the world’s premier biological materials management and standards organization, today announced the promotion of Rebecca Bradford to the position of Vice President, Government Programs in the ATCC Federal Solutions (AFS) business unit, and Linda Johnson to Vice President, Licensing and Intellectual Property Management. Both positions will continue to bring leadership and vision to ATCC’s growth strategy.

ATCC Wins Two Contracts for Leishmaniasis Vaccine, Diagnostic Test

Published on : Published by : Alex Keown

With two new contracts from Gennova Biopharmaceuticals Limited related to the development of a vaccine for Leishmaniasis, Virginia’s ATCC continues to play an increasingly important role in the battle against infectious disease through the development of cell banks for research and other activities.

Virginia’s Pocket Life Science Ecosystems are Booming

Published on : Published by : Alex Keown

There is no doubt that Virginia is open for business to the life sciences industry. Over the past several years, the state has seen significant growth in pocket ecosystems across the land, particularly in areas like Charlottesville, Richmond, and Blacksburg.

ATCC Announces Expansion of its Bioinformatics Data Platform with QIAGEN

ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cell lines and microorganisms.
Published on : Published by : BioBuzz Media

ATCC, the world’s premier biological materials management and standards organization, today announced that it has entered into an agreement with QIAGEN, a recognized leader in bioinformatics solutions, to provide them with sequencing data from its collection of cell lines, and animal and human biological materials. QIAGEN Digital Insights, the bioinformatics unit of QIAGEN, will establish a database from this information to develop and deliver high-value digital biology content for the biotechnology and pharmaceutical industries, enabling the use of authenticated biological data sets to uncover new disease pathways and discover novel therapeutic targets.

ATCC Wins DoD Contract to Identify Novel Antivirals for Infectious Diseases

ATCC logo overtop microscope image of cells
Published on : Published by : Alex Keown

Months after securing a contract valued at up to $545 million from the National Institute of Allergy and Infectious Diseases, Virginia’s ATCC has been awarded three grants valued at over $5.5 million by the Defense Threat Reduction Agency (DTRA) to identify novel therapeutic approaches to treating viruses of global concern.

ATCC Announces Awards from DTRA that Strengthen ATCC’s Antiviral Drug Discovery and Development Portfolio for Global Health and Biodefense

ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cell lines and microorganisms.
Published on : Published by : BioBuzz Media

ATCC, the world’s premier biological materials management and standards organization, announced that it has been awarded three grants valued at over $5.5 million by the Defense Threat Reduction Agency (DTRA). The work will identify and characterize novel therapeutic approaches to viruses of global health concern. Promising therapeutic candidates will be tested for efficacy with in vitro and in vivo model systems.

Samantha Paro Joins ATCC as Sr. Manager, Corporate Communications

Headshot of Samantha Paro of ATCC
Published on : Published by : BioBuzz Media

ATCC (American Type Culture Collection), the world’s premier biological materials management and standards organization, announces the appointment of Samantha Paro as Sr. Manager, Corporate Communications. Samantha Paro joins the ATCC Corporate Communications and Public Affairs team, bringing nearly 15 years experience in communications and marketing. She has prior experience in the entertainment, education, and biopharmaceutical industries. Samantha joins ATCC from AstraZeneca where she most recently led internal communications for the Frederick Biologics Manufacturing Center. In her new role with ATCC, Samantha will develop internal and external communication strategies, plans, and programs in support of ATCC’s mission to provide scientists with the biomaterials and resources they need to conduct critical life science research.

ATCC Wins $545 Million Contract to Respond to Emerging Infectious Disease Threats

Headshot of Joseph Leonelli, SVP of ATCC Federal Solutions
Published on : Published by : Alex Keown

As the world continues to grapple with the ongoing COVID-19 pandemic and the emergence of the new omicron variant, Virginia’s ATCC secured a seven-year Delivery/Indefinite Quantity (IDIQ) contract from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, valued at up to $545 million.